These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2019925)

  • 1. Pancreatic endocrine function in cystic fibrosis.
    Moran A; Diem P; Klein DJ; Levitt MD; Robertson RP
    J Pediatr; 1991 May; 118(5):715-23. PubMed ID: 2019925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
    Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
    Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity in cystic fibrosis.
    Moran A; Pyzdrowski KL; Weinreb J; Kahn BB; Smith SA; Adams KS; Seaquist ER
    Diabetes; 1994 Aug; 43(8):1020-6. PubMed ID: 8039595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
    Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.
    Kilberg MJ; Sheikh S; Stefanovski D; Kubrak C; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
    J Cyst Fibros; 2020 Mar; 19(2):310-315. PubMed ID: 31402215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A; Sheehan AG; Machida H; Parsons HG
    Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lundh meal: a single non-invasive challenge test for evaluation of exocrine and endocrine pancreatic function in cystic fibrosis patients.
    Augarten A; Dubenbaum L; Yahav Y; Katznelson D; Szeinberg A; Blank A; Sack J
    Int J Clin Lab Res; 1999; 29(3):114-6. PubMed ID: 10592108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
    Geffner ME; Lippe BM; Kaplan SA; Itami RM; Gillard BK; Levin SR; Taylor IL
    Pediatr Res; 1984 Nov; 18(11):1107-11. PubMed ID: 6083538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.
    Olivier AK; Yi Y; Sun X; Sui H; Liang B; Hu S; Xie W; Fisher JT; Keiser NW; Lei D; Zhou W; Yan Z; Li G; Evans TI; Meyerholz DK; Wang K; Stewart ZA; Norris AW; Engelhardt JF
    J Clin Invest; 2012 Oct; 122(10):3755-68. PubMed ID: 22996690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
    Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
    J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic morphology and function in adult patients with cystic fibrosis.
    Van Haren EH; Hopman WP; Rosenbusch G; Jansen JB; Van Herwaarden CL
    Scand J Gastroenterol; 1992 Aug; 27(8):695-8. PubMed ID: 1439553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.
    Yi Y; Sun X; Gibson-Corley K; Xie W; Liang B; He N; Tyler SR; Uc A; Philipson LH; Wang K; Hara M; Ode KL; Norris AW; Engelhardt JF
    Endocrinology; 2016 May; 157(5):1852-65. PubMed ID: 26862997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.
    Keller U; Szöllösy E; Varga L; Gyr K
    Dig Dis Sci; 1984 Sep; 29(9):853-7. PubMed ID: 6381002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tests of exocrine and endocrine pancreatic function in older patients with cystic fibrosis.
    Lamers CB; Jansen JB; Hafkenscheid JC; Jongerius CM
    Pancreas; 1990; 5(1):65-9. PubMed ID: 1688391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic polypeptide in cystic fibrosis.
    Nousia-Arvanitakis S; Tomita T; Desai N; Kimmel JR
    Arch Pathol Lab Med; 1985 Aug; 109(8):722-6. PubMed ID: 3893382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.
    Ilag LL; Tabaei BP; Herman WH; Zawacki CM; D'Souza E; Bell GI; Fajans SS
    Diabetes; 2000 Jun; 49(6):961-8. PubMed ID: 10866048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
    Kessler L; Abély M
    Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
    Hinds A; Sheehan AG; Parsons HG
    Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.